NDC 11523-4357-05 - MiraLAX
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11523-4357
- Requested NDC
- 11523-4357-05
- Package NDCs from labels
- 11523-4357-1, 11523-4357-3, 11523-4357-5, 11523-4357-2, 11523-4357-05
- Manufacturer
- Bayer HealthCare LLC.
- Effective date
- 2026-05-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MiraLAX ® | Bayer HealthCare LLC. | 2026-05-04 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11523-4357-1 | MiraLAX | 2 in 1 PACKAGE, COMBINATION | POWDER, FOR SOLUTION | 2 | 24 | |
| 11523-4357-1 | MiraLAX | 765 g in 1 BOTTLE, PLASTIC | POWDER, FOR SOLUTION | 765 | 24 | |
| 11523-4357-2 | MiraLAX | 20 in 1 CARTON | POWDER, FOR SOLUTION | 20 | 24 | |
| 11523-4357-2 | MiraLAX | 2 in 1 CARTON | POWDER, FOR SOLUTION | 2 | 24 | |
| 11523-4357-3 | MiraLAX | 2 in 1 PACKAGE, COMBINATION | POWDER, FOR SOLUTION | 2 | 24 | |
| 11523-4357-3 | MiraLAX | 578 g in 1 BOTTLE, PLASTIC | POWDER, FOR SOLUTION | 578 | 24 | |
| 11523-4357-5 | MiraLAX | 17 g in 1 PACKET | POWDER, FOR SOLUTION | 17 | 24 | |
| 11523-4357-5 | MiraLAX | 24 in 1 CARTON | POWDER, FOR SOLUTION | 24 | 24 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 11523-4357 | MIRALAX (POLYETHYLENE GLYCOL 3350) POWDER, FOR SOLUTION [BAYER HEALTHCARE LLC.] | 22 | Current NDC, Legacy NDC, 8 package rows | 20241208_d69ce3d4-7ca4-4fe3-b49e-6655e48d6963.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 11523-4357-3 | GM - Gram | 11523-4357 | c98dcd88-dfc7-488c-b201-0728a80162fa | 1 | 2025-05-14 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Polyethylene Glycol 3350 | ACTIVE INGREDIENT | G2M7P15E5P | MIRALAX (POLYETHYLENE GLYCOL 3350) POWDER, FOR SOLUTION [MSD CONSUMER CARE, INC.] | 9 | |
| Polyethylene Glycol 3350 | ACTIVE MOIETY | G2M7P15E5P | MIRALAX (POLYETHYLENE GLYCOL 3350) POWDER, FOR SOLUTION [MSD CONSUMER CARE, INC.] | 9 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | American Health Packaging | 81374641-e54c-4b41-a3ad-49b19a097666 | 2026-02-18 | Warnings | 876193 G2M7P15E5P |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | GLENMARK THERAPEUTICS INC., USA | 5aba6bb1-d25d-4901-8e9c-4cd4a3a06471 | 2026-01-27 | Warnings | 876193 G2M7P15E5P |
| Good Sense Clear Lax | POLYETHYLENE GLYCOL 3350 | Preferred Pharmaceuticals Inc. | 935f05da-3637-4a9e-843e-1f2ced5d1a74 | 2026-01-23 | Warnings | 876193 G2M7P15E5P |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | YYBA Corp | 48488531-5d04-4af6-e063-6294a90afe4b | 2026-01-13 | Warnings | 876193 G2M7P15E5P |
| EasyLAX | POLYETHYLENE GLYCOL 3350 | VALU MERCHANDISERS COMPANY | 6597811b-6471-5afd-e053-2991aa0a07c2 | 2025-12-16 | Warnings | 876193 G2M7P15E5P |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | ANI Pharmaceuticals, Inc. | 1afff730-b2d3-4e01-8403-97f2ecef3a74 | 2025-12-10 | Warnings | 876193 G2M7P15E5P |
| GAVILAX | POLYETHYLENE GLYCOL 3350 | Lupin Pharmaceuticals,Inc. | 19672e23-1606-497e-a112-939af33af195 | 2025-12-08 | Warnings | 876193 G2M7P15E5P |
| MiraLAX Orange Flavor | POLYETHYLENE GLYCOL 3350 | Bayer HealthCare LLC. | 0a5b2121-928f-8f49-e063-6394a90a8aaf | 2025-12-04 | Warnings | 876193 876195 G2M7P15E5P |
| Walgreens | POLYETHYLENE GLYCOL 3350 | WALGREEN COMPANY | 97489a02-db59-4529-a091-abc737e44a96 | 2025-12-01 | Warnings | 876193 G2M7P15E5P |
| MiraLAX | POLYETHYLENE GLYCOL 3350 | Cardinal Health 107, LLC | 1771d3bf-954d-49ea-b260-3d356e5dcfa5 | 2025-11-07 | Warnings | NDA022015 876193 876195 G2M7P15E5P |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | A-S Medication Solutions | 4f31a33e-1f60-4aa7-b1dc-a3c011c03a70 | 2025-10-29 | Warnings | 876193 G2M7P15E5P |
| Polyethylene Glycol 3350 Powder for Solution | POLYETHYLENE GLYCOL, UNSPECIFIED | VALLEY MEDICAL PRODUCTS, LLC | ae595e97-6d29-44f8-a647-fcd54fcda5b1 | 2025-10-27 | Warnings | 876193 G2M7P15E5P |
| Polyethylene glycol 3350 | POLYETHYLENE GLYCOL 3350 | Cardinal Health 107, LLC | 2f5c975f-0d35-4f68-a27c-28af9a898733 | 2025-10-23 | Warnings | 876193 G2M7P15E5P |
| MiraLAX | POLYETHYLENE GLYCOL 3350 | ASCLEMED USA INC. | e652042f-3707-4bf6-831d-d806638b7d85 | 2025-10-14 | Warnings | NDA022015 876193 876195 G2M7P15E5P |
| Laxative | POLYETHYLENE GLYCOL 3350 | Rite Aid Corporation | 457f5d2d-4595-482a-9ffa-659fb5d5b134 | 2025-10-09 | Warnings | 876193 G2M7P15E5P |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | Bryant Ranch Prepack | 5df518fb-ad58-4f17-af34-f66066f1313a | 2025-09-30 | Warnings | 876193 G2M7P15E5P |
| Dulcolax | POLYETHYLENE GLYCOL 3350 | Chattem, Inc. | ed16d0f4-74e7-4fa3-989d-c6840a5d3e71 | 2025-09-30 | Warnings | 876193 G2M7P15E5P |
| kirkland signature laxaclear original prescription strength | POLYETHYLENE GLYCOL 3350 | Costco Wholesale Company | f58fa5c0-8ab7-4427-aea0-d536b47acbb5 | 2025-09-18 | Warnings | 876193 G2M7P15E5P |
| up and up powderlax | POLYETHYLENE GLYCOL 3350 | Target Corporation | 1bceb457-b24f-485d-bfe2-af4b7d38a5c2 | 2025-09-18 | Warnings | 876193 G2M7P15E5P |
| GAVILYTE-N | POLYETHYLENE GLYCOL-3350, SODIUM CHLORIDE, POTASSIUM CHLORIDE AND SODIUM BICARBONATE | Lupin Pharmaceuticals,Inc. | 27195187-75a3-431f-90d9-84da1b94e849 | 2025-09-10 | Warnings, Adverse reactions | G2M7P15E5P |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.